Total Payments
$7,624
2024 Payments
$14.97
Companies
42
Transactions
622
Medicare Patients
10,410
Medicare Billing
$369,998
Payment Breakdown by Category
Food & Beverage$7,577 (99.4%)
Education$46.90 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,577 | 616 | 99.4% |
| Education | $46.90 | 6 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $861.76 | 9 | $0 (2021) |
| Allergan, Inc. | $811.47 | 70 | $0 (2020) |
| PFIZER INC. | $659.03 | 111 | $0 (2024) |
| Novo Nordisk Inc | $653.11 | 51 | $0 (2021) |
| Lilly USA, LLC | $567.54 | 52 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $504.98 | 37 | $0 (2022) |
| GlaxoSmithKline, LLC. | $479.54 | 56 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $449.11 | 36 | $0 (2021) |
| Amgen Inc. | $441.69 | 32 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $428.97 | 41 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.97 | 1 | PFIZER INC. ($14.97) |
| 2023 | $15.19 | 1 | Xeris Pharmaceuticals, Inc. ($15.19) |
| 2022 | $88.18 | 6 | Lilly USA, LLC ($33.22) |
| 2021 | $1,041 | 64 | AbbVie Inc. ($281.32) |
| 2020 | $1,057 | 64 | AstraZeneca Pharmaceuticals LP ($253.55) |
| 2019 | $1,666 | 149 | PFIZER INC. ($200.35) |
| 2018 | $1,868 | 169 | Allergan Inc. ($278.07) |
| 2017 | $1,873 | 168 | Allergan Inc. ($325.40) |
All Payment Transactions
622 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: VACCINES | ||||||
| 02/22/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 09/05/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Neuroscience | ||||||
| 07/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Diabetes | ||||||
| 05/05/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Cardio-renal | ||||||
| 05/03/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/07/2022 | Baxter Healthcare | Hillrom - Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Airway Clearance Device | ||||||
| 12/22/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardio-renal | ||||||
| 12/10/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Diabetes | ||||||
| 12/10/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Diabetes | ||||||
| 11/01/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Diabetes | ||||||
| 09/17/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), VERQUVO, STEGLATRO | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/01/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2021 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/03/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Diabetes | ||||||
| 07/29/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/21/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Diabetes | ||||||
| 07/16/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Diabetes | ||||||
| 07/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/06/2021 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 38 | 4,000 | 6,801 | $160,167 | $113,839 |
| 2020 | 52 | 6,410 | 12,981 | $336,593 | $256,159 |
Total Patients
10,410
Total Services
19,782
Medicare Billing
$369,998
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 415 | 820 | $60,179 | $35,412 | 58.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 126 | 126 | $14,289 | $14,252 | 99.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 14 | 840 | $15,995 | $12,357 | 77.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 412 | 728 | $10,609 | $7,610 | 71.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 97 | $10,647 | $6,224 | 58.5% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2021 | 431 | 788 | $7,015 | $5,051 | 72.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 250 | 279 | $6,431 | $4,687 | 72.9% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2021 | 65 | 108 | $5,028 | $4,240 | 84.3% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 118 | 118 | $3,362 | $3,311 | 98.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 431 | 886 | $2,667 | $2,633 | 98.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 250 | 278 | $3,338 | $2,499 | 74.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2021 | 99 | 101 | $2,089 | $1,523 | 72.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 111 | 157 | $2,105 | $1,501 | 71.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 98 | 106 | $1,931 | $1,419 | 73.5% |
| 82465 | Cholesterol level | Office | 2021 | 250 | 302 | $1,803 | $1,314 | 72.9% |
| 86769 | Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | Office | 2021 | 22 | 24 | $1,011 | $1,011 | 100.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 15 | 17 | $872.27 | $872.27 | 100.0% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 48 | 48 | $813.12 | $787.82 | 96.9% |
| 82728 | Ferritin (blood protein) level | Office | 2021 | 50 | 54 | $1,010 | $736.02 | 72.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 65 | 74 | $858.40 | $626.04 | 72.9% |
| 82306 | Vitamin d-3 level | Office | 2021 | 20 | 21 | $852.81 | $621.60 | 72.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2021 | 31 | 31 | $777.79 | $598.61 | 77.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 69 | 74 | $1,173 | $568.26 | 48.4% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2021 | 97 | 138 | $663.72 | $501.60 | 75.6% |
| 85610 | Blood test, clotting time | Office | 2021 | 27 | 92 | $495.88 | $394.68 | 79.6% |
About Dr. Richard French, MD
Dr. Richard French, MD is a Internal Medicine healthcare provider based in Hastings, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003819699.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard French, MD has received a total of $7,624 in payments from pharmaceutical and medical device companies, with $14.97 received in 2024. These payments were reported across 622 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($7,577).
As a Medicare-enrolled provider, French has provided services to 10,410 Medicare beneficiaries, totaling 19,782 services with total Medicare billing of $369,998. Data is available for 2 years (2020–2021), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Hastings, NE
- Active Since 05/27/2005
- Last Updated 01/04/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003819699
Products in Payments
- TRULICITY (Drug) $428.02
- XARELTO (Drug) $412.13
- Ozempic (Drug) $381.60
- CHANTIX (Drug) $355.78
- FARXIGA (Drug) $270.35
- BYDUREON (Drug) $262.97
- BYSTOLIC (Drug) $258.45
- TRADJENTA (Drug) $231.13
- UBRELVY (Drug) $212.83
- Trintellix (Drug) $195.58
- SYMBICORT (Drug) $193.73
- Aimovig (Biological) $188.47
- TRELEGY ELLIPTA (Drug) $166.26
- EVENITY (Biological) $165.70
- TOUJEO (Drug) $164.43
- VIBERZI (Drug) $163.34
- ELIQUIS (Drug) $153.01
- Victoza (Drug) $143.98
- LINZESS (Drug) $142.28
- SOLIQUA (Drug) $136.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hastings
Justin Wenburg, Md, MD
Internal Medicine — Payments: $13,260
Internal Medicine $13,260
Dr. Douglas Hentzen, M.d, M.D
Internal Medicine — Payments: $12,047
Internal Medicine $12,047
Paul Wibbels, Md, MD
Internal Medicine — Payments: $11,017
Internal Medicine $11,017
Matthew Stritt, Md, MD
Internal Medicine — Payments: $5,750
Internal Medicine $5,750
Michelle Seizys, Md, MD
Internal Medicine — Payments: $5,136
Internal Medicine $5,136
David Little, Md, MD
Internal Medicine — Payments: $3,987
Internal Medicine $3,987